0001437749-21-013625.txt : 20210528
0001437749-21-013625.hdr.sgml : 20210528
20210528083022
ACCESSION NUMBER: 0001437749-21-013625
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170712
FILED AS OF DATE: 20210528
DATE AS OF CHANGE: 20210528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aubrey de Lavenu Harold Andre
CENTRAL INDEX KEY: 0001737899
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55557
FILM NUMBER: 21976285
MAIL ADDRESS:
STREET 1: APT 627 VALE DO LOBO
CITY: ALMANCIL
STATE: S1
ZIP: 8135-034
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEN BIOTECH INC
CENTRAL INDEX KEY: 0001653821
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
BUSINESS PHONE: 226-344-0660
MAIL ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
3/A
1
rdgdoc.xml
FORM 3/A
X0206
3/A
2017-07-12
2021-04-22
0
0001653821
CEN BIOTECH INC
CENBF
0001737899
Aubrey de Lavenu Harold Andre
300-3295 QUALITY WAY
WINDSOR, ONTARIO, CANADA
A6
N8T 3R9
ONTARIO, CANADA
1
Common Stock
13321
D
Convertible Note
1.6000
2016-05-24
Common Stock
62500
D
Convertible Note
1.6000
2016-11-25
Common Stock
125000
D
Convertible Note
1.6000
2016-12-14
Common Stock
156250
D
Convertible Note
1.6000
2017-02-09
Common Stock
312500
D
Harold Aubrey de Lavenu (the "Reporting Person") was appointed to his position with CEN Biotech, Inc. (the "Issuer") on July 12, 2017 and owned 13,321 shares of the Issuer's common stock on such date. On April 2, 2021, the Issuer appointed the Reporting Person to serve as a Vice President of the Issuer effective as of April 2, 2021
Additionally the Reporting Person owned convertible notes on July 12, 2017, which the Reporting Person purchased from the Issuer which were at such time and still are convertible into 656,250 shares of the Issuer's common stock.
The convertible notes included in this table matured on May 12, 2018, November 25, 2018, December 14, 2018, and February 19, 2019, respectively, (the "Maturity Dates"), however, the ability to convert the notes into shares did not expire on the Maturity Dates of the notes.
/s/ Harold Aubrey de Lavenu
2021-05-28